EEVIA HEALTH OYJ |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.588 SEK | +0.34% |
|
-2.65% | -44.00% |
| 06-13 | Eevia Receives Start Order from a New Australian Customer for EUR 69,000 | CI |
| 05-22 | Eevia Health Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 12.34 | 2.446 | 3.368 |
| Enterprise Value (EV) 1 | 11.03 | 2.79 | 4.029 |
| P/E ratio | -5.36 x | -2.28 x | -3.8 x |
| Yield | - | - | - |
| Capitalization / Revenue | 1.81 x | 0.42 x | 0.73 x |
| EV / Revenue | 1.62 x | 0.48 x | 0.87 x |
| EV / EBITDA | -5.25 x | -3.02 x | -86.3 x |
| EV / FCF | - | -984,137 x | -4,203,058 x |
| FCF Yield | - | -0% | -0% |
| Price to Book | 4.04 x | 1.38 x | 0.98 x |
| Nbr of stocks (in thousands) | 13,952 | 15,973 | 35,714 |
| Reference price 2 | 0.8844 | 0.1531 | 0.0943 |
| Announcement Date | 5/31/22 | 6/13/23 | 6/7/24 |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.321 | 1.404 | 2.928 | 6.808 | 5.763 | 4.609 |
| EBITDA 1 | -0.6641 | -0.2548 | -0.6938 | -2.1 | -0.9242 | -0.0467 |
| EBIT 1 | -0.8127 | -0.3689 | -0.9229 | -2.59 | -1.474 | -0.6618 |
| Operating Margin | -61.52% | -26.27% | -31.52% | -38.04% | -25.58% | -14.36% |
| Earnings before Tax (EBT) 1 | -0.8348 | -0.4073 | -1.023 | -2.636 | -2.043 | -0.8858 |
| Net income 1 | -0.8348 | -0.4073 | -1.023 | -2.636 | -2.043 | -0.8858 |
| Net margin | -63.19% | -29% | -34.95% | -38.71% | -35.44% | -19.22% |
| EPS 2 | -0.1670 | - | - | -0.1650 | -0.0673 | -0.0248 |
| Free Cash Flow | - | - | - | - | -2.835 | -0.9585 |
| FCF margin | - | - | - | - | -49.19% | -20.8% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/15/19 | 8/15/20 | 5/10/21 | 5/31/22 | 6/13/23 | 6/7/24 |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 0.34 | 0.66 |
| Net Cash position 1 | 0.11 | 0.58 | 0.51 | 1.31 | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | -0.3724 x | -14.16 x |
| Free Cash Flow | - | - | - | - | -2.84 | -0.96 |
| ROE (net income / shareholders' equity) | -283% | -48.6% | -109% | -134% | -59.5% | -26% |
| ROA (Net income/ Total Assets) | -57.8% | -16.1% | -13.9% | -21.7% | -11.6% | -6.43% |
| Assets 1 | 1.445 | 2.531 | 7.37 | 12.17 | 17.59 | 13.77 |
| Book Value Per Share 2 | 0.0400 | - | - | 0.2200 | 0.1100 | 0.1000 |
| Cash Flow per Share 2 | 0.0200 | - | - | 0.1200 | 0.0200 | 0 |
| Capex | - | - | - | - | 0.85 | 0.73 |
| Capex / Sales | - | - | - | - | 14.83% | 15.87% |
| Announcement Date | 8/15/19 | 8/15/20 | 5/10/21 | 5/31/22 | 6/13/23 | 6/7/24 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- EEVIA Stock
- Financials Eevia Health Oyj
